Back to Results
First PageMeta Content
Immunology / Biology / Alemtuzumab / Genzyme / Sanofi / Interferon beta-1a / CD52 / Interferon / Therapies under investigation for multiple sclerosis / Multiple sclerosis / Cytokines / Immune system


PRESS RELEASE European Commission Approves Genzyme’s Multiple Sclerosis
Add to Reading List

Document Date: 2013-09-17 12:37:08


Open Document

File Size: 83,00 KB

Share Result on Facebook
UPDATE